| Style | Citing Format |
|---|---|
| MLA | Vahabi SM, et al.. "Beyond Autoantibodies: Identifying Clinically Relevant Biomarkers in Morphea." International Journal of Dermatology, vol. 65, no. 7, 2026, pp. 1560-1563. |
| APA | Vahabi SM, Memari H, Montazeri S, Hosseini F, Etesami I, Ansari MS (2026). Beyond Autoantibodies: Identifying Clinically Relevant Biomarkers in Morphea. International Journal of Dermatology, 65(7), 1560-1563. |
| Chicago | Vahabi SM, Memari H, Montazeri S, Hosseini F, Etesami I, Ansari MS. "Beyond Autoantibodies: Identifying Clinically Relevant Biomarkers in Morphea." International Journal of Dermatology 65, no. 7 (2026): 1560-1563. |
| Harvard | Vahabi SM et al. (2026) 'Beyond Autoantibodies: Identifying Clinically Relevant Biomarkers in Morphea', International Journal of Dermatology, 65(7), pp. 1560-1563. |
| Vancouver | Vahabi SM, Memari H, Montazeri S, Hosseini F, Etesami I, Ansari MS. Beyond Autoantibodies: Identifying Clinically Relevant Biomarkers in Morphea. International Journal of Dermatology. 2026;65(7):1560-1563. |
| BibTex | @article{ author = {Vahabi SM and Memari H and Montazeri S and Hosseini F and Etesami I and Ansari MS}, title = {Beyond Autoantibodies: Identifying Clinically Relevant Biomarkers in Morphea}, journal = {International Journal of Dermatology}, volume = {65}, number = {7}, pages = {1560-1563}, year = {2026} } |
| RIS | TY - JOUR AU - Vahabi SM AU - Memari H AU - Montazeri S AU - Hosseini F AU - Etesami I AU - Ansari MS TI - Beyond Autoantibodies: Identifying Clinically Relevant Biomarkers in Morphea JO - International Journal of Dermatology VL - 65 IS - 7 SP - 1560 EP - 1563 PY - 2026 ER - |